Cytotoxic anticancer agents and renal impairment study: the challenge remains.
Rahman
Atiqur
A
White
Robert M
RM
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D005492:Folic Acid / Q000008:administration & dosage; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D005971:Glutamates / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D006147:Guanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D000068437:Pemetrexed; D014805:Vitamin B 12 / Q000008:administration & dosage
D000964:Antimetabolites, Antineoplastic; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine; D005492:Folic Acid; D014805:Vitamin B 12